Cell Signal Transduction and Diseases

44
Cell Signal Transduction and Diseases Jimin Shao ( 邵邵邵 ) Professor, Dept. Pathology and Pathophysiology Tel: 88208209 E-mail: [email protected]

description

Cell Signal Transduction and Diseases. Jimin Shao ( 邵吉民 ) Professor, Dept. Pathology and Pathophysiology Tel: 88208209 E-mail: [email protected]. Introduction: Cell signaling and Signal transduction (1) Cell signaling (2) Types of cellular signals (3) Functions - PowerPoint PPT Presentation

Transcript of Cell Signal Transduction and Diseases

Page 1: Cell Signal Transduction and Diseases

Cell Signal Transduction and Diseases

Jimin Shao ( 邵吉民 )Professor, Dept. Pathology and PathophysiologyTel: 88208209E-mail: [email protected]

Page 2: Cell Signal Transduction and Diseases

1. Introduction: Cell signaling and Signal transduction (1) Cell signaling

(2) Types of cellular signals

(3) Functions

2. Gap junction and diseases

(1) Structure of gap junction

(2) Function of gap junction

(3) Related diseases

3. Receptor-Mediated Signal Transduction and diseases (1) Cell-surface receptors (2) Nuclear receptors (3) Regulatory mechanisms of signal transduction

(4) Disorders and related diseases

Page 3: Cell Signal Transduction and Diseases

Introduction: Cell signaling and Signal transduction

1. Cell Signaling

(1) Direct Intercellular Communication

Gap Junction

(2) Signaling by plasma-membrane bound molecules

(3) Receptor-Mediated Intercellular communication

Cell-Surface Receptors

Nuclear Receptors

Gap Junction

Page 4: Cell Signal Transduction and Diseases

2. Types of cellular signals

(1) Chemical signals

Hormones, neurotransmitters, growth factors, cytokines;

odor molecules; ATP, active oxygen; drugs, toxins, etc

(2) Physical signals Light, electronic, mechanic, UV, heat, volume, osmotic, etc

Page 5: Cell Signal Transduction and Diseases

Endocrine Act on a far away organ via blood circulation, seen in most hormones

Paracrine Act on a nearby target, seen in GFs, CKs, etc Synaptic: Presynaptic to postsynaptic (neurotransmitters) Autocrine Act on itself after secreted, seen in GFs, especially in tumor tissues Intracrine Act on itself before secreted, seen in nuclear receptors

(3) Modes for the function of endogenous signals

Page 6: Cell Signal Transduction and Diseases

Microvesicles are membrane-enclosed extracellular vesicles shed from the plasma membrane or derived from the endosomal membrane of cells , which can mediate intercellular communication through transferring the vesicular components to recipient cells.

Page 7: Cell Signal Transduction and Diseases

3. Cell Signal Transduction Pathways--Physiological functions--Metabolism--Cell cycle, growth, differentiation, and apoptosis--Responses to stress--etc.

LPSTNFIL-1

Page 8: Cell Signal Transduction and Diseases

1. Structure of Gap Junction Connexins are four-pass transmembrane proteins,

six of which assemble to form a channel, a connexon. ~ 20 different isoforms of connexins in humans and mice

Gap junction

Page 9: Cell Signal Transduction and Diseases

• Used by most cells in animal tissues with the exception of a few terminally differentiated cells, such as skeletal muscle cells and blood cells

• Allowing inorganic ions and other small water-soluble molecules to pass directly from one cell to the other, thus coupling the cells both electrically and metabolically

In electrically excitable cells such as nerve cells allow action potential to spread rapidly without the delay that occurs at chemical synapses

The sharing of small metabolites and ions provides a mechanism for coordinating the activities of individual cells (metabolic cooperation)

2. Function of Gap Junction

Page 10: Cell Signal Transduction and Diseases

3. Gap Junction in Diseases

• Connexin gene mutation and Diseases – Congenital non-syndromatic deafness (Cx26 mutation) – Congenital cataract (Cx50 mutation) – Axonal degeneration of peripheral nerves (Cx32 mutation)– Infertility of females (Cx37)

• Gap junction and tumor promotion -- Gap junction intercellular communication down-regulated • Gap junction and embryogenesis -- embryo development (Cx43) -- nutrients transportation (Cx26)• Others

Page 11: Cell Signal Transduction and Diseases

Receptors: Cell Surface Receptors; Nuclear Receptors

Receptor-Mediated Signal Transduction Systems

Page 12: Cell Signal Transduction and Diseases

1. Process of transmembrane signal transduction

Cell-surface receptors

Synthesis and secretion of signaling molecules Receptor binding and initiation of intracellular signaling

pathway Regulation of cellular metabolism, function, gene expression, etc Down-regulation or termination of cellular responses

Page 13: Cell Signal Transduction and Diseases

2. Classification of cell-surface receptors• Ion-channel-linked receptors

– Involved in rapid synaptic signaling between electrically excitable cells

• G-protein coupled receptors (GPCR)– Seven-pass transmembrane protein, – indirectly regulate the activity of a target protein through a trimeric GTP-binding

protein (G-protein)

• Enzyme-linked receptors– Single-pass transmembrane protein, – function directly as enzyme or directly associated with enzymes they activate

• Others

Page 14: Cell Signal Transduction and Diseases
Page 15: Cell Signal Transduction and Diseases

Ion Channel Linked Receptor(Ligand-gated Ion Channel)

1. Classification: Class I nAchR, GABAR, 5-HT3R, GlyR

Class II Glutamate/Aspartate Receptor

Class III cGMP/cAMPR, IP3R, ryanodine R

Class IV ATP/ADP gated channel (P2X)

2. Structure:

Page 16: Cell Signal Transduction and Diseases

3. Involved in rapid synaptic signaling between electrically excitable cells--A model for iGluR activation and desensitization

Page 17: Cell Signal Transduction and Diseases

1. General process:

Signaling through GPCR

GPCR (Seven-pass transmembrane protein):

Adrenergic R, mAchR, opioid R,

chemokine R, etc

Page 18: Cell Signal Transduction and Diseases

G-protein: Three non-identical subunits

Page 19: Cell Signal Transduction and Diseases

(2) Gq: Gq activates the inositol phospholipid signaling pathway by activating phospholipase C- (PLC- PLC- acts on phosphatidylinositol 4,5-biphosphate [PI(4,5)P2] to generate: inositol (1,4,5)-triphosphate (IP3) ; diacylglycerol (DAG).

2. GαSignaling pathways

(1) Gs, Gi:Stimulatory G protein (Gs), activates Ac; Inhibitory G protein (Gi), inhibits Ac.cAMP is synthesized from ATP by adenylyl cyclase, and rapidly hydrolyzed by cAMP phosphodiesterase.Usually the α subunit regulates the cyclase, although βγ complex may does so as well.

Page 20: Cell Signal Transduction and Diseases

GPCR Signaling Pathways• GPCR—GP—Ac—cAMP—PKA—CREB(CRE-binding protein) + CBP—CRE of target gene• GPCR—GP—PLCβ —IP3—Ca2+ — Calmodulin—CaM-Kinase — DAG + Ca2+ — PKC

Regulator of G-protein signaling

DAG

Page 21: Cell Signal Transduction and Diseases

•Classically, GPCR signaling is mediated through coupling to heterotrimeric G proteins, subsequently triggering a series of intracellular signaling cascades and ultimately leading to changes in cellular physiology. •After their activation, various GPCRs are phosphorylated by GPCR kinases (GRKs) and subsequently recruit one or both of the two isoforms of cytosolic b-arrestins (b-arrestin1 and b-arrestin2). b-Arrestin binding uncouples the receptor from the G protein, thus terminating or attenuating G protein–mediated signaling (desensitization), and facilitates clathrin-mediated endocytosis (internalization) of the receptor. •In addition to their role in the termination of G protein–mediated signaling, b-arrestins also serve as multifunctional adaptors and signal transducers, linking GPCRs to a growing list of signaling molecules, including mitogen-activated protein kinase (MAPK), the tyrosine kinase c-Src, and the Ser-Thr kinase Akt.•Whereas classical agonists stimulate both G protein–mediated and b-arrestin–mediated signaling mechanisms, “biased ligands” can selectively activate G protein or b-arrestin functions and thus elicit distinct biological effects.•Phosphorylation of GPCRs on their C termini and intracellular loops by GRKs is generally required for b-arrestin binding. •In contrast to the plethora of GPCRs, there are only seven members in the GRK family, and of those, only GRKs 2, 3, 5, and 6 are ubiquitously expressed. •Studies suggest that distinct GRKs may contribute differently to the processes of receptor desensitization, endocytosis, and signaling.•We hypothesized that the different GRKs might phosphorylate distinct sets of sites on the C terminus and internal loops of the receptor, thereby establishing a “barcode” that would instruct or determine the conformation assumed by the b-arrestin, which would, in turn, determine its functional capabilities.

Extended reading

Page 22: Cell Signal Transduction and Diseases

Signaling through enzyme-linked cell-surface receptors

1. Receptor tyrosine kinases

2. Tyrosine-kinase-associated receptors

3. Receptor serine/threonine kinases

4. Receptor guanylyl cyclases

5. others

Page 23: Cell Signal Transduction and Diseases

1. Receptor tyrosine kinases• Many secreted growth factors and hormones act through receptor

tyrosine kinases:– Epithelial growth factor (EGF), – platelet-derived growth factor (PDGF), – fibroblast growth factors (FGFs), – hepatocyte growth factor (HGF), – insulin, insulinlike growth factor-1 (IGF-1), – vascular endothelial growth factor (VEGF), – macrophage-colony-stimulating factor (M-CGF), – neurotrophins

• Many cell-surface-bound signal proteins also act through receptor tyrosine kinases– Ephrins (Eph): regulates cell adhesion and repulsion response that guide the

migration of cells and axons during development– Eph receptors: receptor tyrosine kinases– Bidirectional signaling: binding to Eph receptor can cause the activation of

both Eph and Eph receptor, thus changing the behavior of both cells

Page 24: Cell Signal Transduction and Diseases

•Activated receptor tyrosine kinases phosphorylate themselves

Page 25: Cell Signal Transduction and Diseases

(1) RAS-MAPK PathwayGF--RTK--GRB2—Ras GEF—Ras –-MAPKKK—MAPKK--MAPK (Raf—MEK1/2—ERK1/2)

MAPKs:ERK

JNK/SAPK

p38MAPK

etc

Page 26: Cell Signal Transduction and Diseases
Page 27: Cell Signal Transduction and Diseases

(2) PI3-kinase/Protein kinase B pathway• PKB (or Akt) containing a PH domain --Binds to PI(3,4,5)P3 --Activated by a phosphatidylinositol-dependent protein kinase PDK1 --Phosphorylates and inactivates BAD, a pro-apoptosis factor, promotes cell survival

Page 28: Cell Signal Transduction and Diseases

Extended Reading:

Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13(5):283-96.

Role of PTEN

Cell metabolism

Cell mobility and polarity

Tumor microenvironment

Cell senesence

Cancer stem cell

Nuclear function

PI3K-AKT independent functions

Page 29: Cell Signal Transduction and Diseases

The PTEN–PI3K–AKT–mTOR pathway

Page 30: Cell Signal Transduction and Diseases
Page 31: Cell Signal Transduction and Diseases

Functions of PTEN in the nucleus

Page 32: Cell Signal Transduction and Diseases

Regulation of PTEN

Genetic alteration

Epigenetic regulation

Post-transcriptional regulation

Post-translational modification

Protein-protein interaction

Page 33: Cell Signal Transduction and Diseases

(3) Cross-talk between signaling pathways activated by GPCRs and RTKs

Page 34: Cell Signal Transduction and Diseases

2. Tyrosine-kinase-associated receptors

Cytokines --receptors --Jak-STAT signal pathway•Ligands: interferons, cytokines, etc • JAK family: JAK1-3, Tyk 2 (Just Another Kinase/Janus Kinase) (cytoplasmic tyrosine kinases)• STAT family: STAT1-7 (Signal Transducer and Activator of Transcription

• Jaks phosphorylate and activate STATs, STATs then move to the nucleus and stimulate transcription

STATs contain SH2 domain and also dock onto specific activated Receptor TK, thus being activated independent of Jaks.

Page 35: Cell Signal Transduction and Diseases
Page 36: Cell Signal Transduction and Diseases

3. Receptor serine/threonine kinasesTGF- superfamily--receptor serine/threonine kinases--Smads Signal Pathway

• Transforming growth factor- superfamily: TGF-s, activins, bond morphogenetic proteins (BMPs), etc• TGF-β Receptor Superfamily: Protein serine/threonine kinase; Single pass transmembrane receptor; Type I and II• The ligand first binds to and activates type II homodimer, which

recruits, phosphorylates, and activates a type I receptor dimer, forming a tetrameric receptor complex

• Smads

Page 37: Cell Signal Transduction and Diseases
Page 38: Cell Signal Transduction and Diseases

4. Receptor guanylyl cyclases• Receptor guanylyl cyclases: single pass transmembrane proteins.• Generates cGMP in response to stimuli. • cGMP binds/activates a cGMP-dependent serine/threonine protein kinase (PKG).• Atrial natriuretic peptides (ANPs) as signal molecules: regulate salt and water

balance and dilate blood vessels.

Page 39: Cell Signal Transduction and Diseases

Extended Reading:Majid S, Saini S, Dahiya R. Wnt signaling pathways in urological cancers: past decades and still

growing. Mol Cancer. 2012;11(1):7.

Page 40: Cell Signal Transduction and Diseases

• Nuclear receptors are ligand-activated gene regulatory proteinsSteroid ReceptorsRetinoid ReceptorsOrphan Receptors

Others• Some small hydrophobic signal molecules, such as steroids,

thyroids, retinoids, and vitamin D, can diffuse directly across the plasma membrane to bind to nuclear receptors

• Primary response• Secondary response

Nuclear Receptors

Page 41: Cell Signal Transduction and Diseases
Page 42: Cell Signal Transduction and Diseases

Regulatory Mechanisms of Signal transduction

• Posttranslational Modification (PTM):

Phosphorylation, Acetylation, Methylation, SUMO, Ubiquitin, etc

• Protein-Protein Interaction and Protein Complex:

Homodimer, Heterodimer, Polymer, etc

Protein-DNA/RNA/Lipid/small molecules, etc

•Domains and signaling network:

SH2(pTyr), SH3(PXXP), PH, etc

Page 43: Cell Signal Transduction and Diseases
Page 44: Cell Signal Transduction and Diseases

Jason I. Herschkowitz and Xiaoyong Fu. MicroRNAs Add an Additional Layer to the Complexity of Cell Signaling. Sci. Signal.4 (184), jc5. [DOI: 10.1126/scisignal.2002182]

Extended Reading